Covid: US calls for pause on Johnson & Johnson vaccine after clotting cases

The US FDA is asking states to pause using Johnson & Johnson's Covid-19 vaccine after six people in the US developed a rare disorder involving blood clots

Federal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination, officials briefed on the decision said.

All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition, the officials said.

Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped